Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor administrative update to the study details page without altering the trial information.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This indicates a small update to the page's metadata, without changing substantive content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer page revision. This update does not modify study details or user-facing content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page shows Revision: v3.6.3 in place of Revision: v3.6.2, indicating a small software update applied to the page rather than a change to the study data or details.SummaryDifference0.0%

- Check76 days agoChange DetectedA new revision tag Revision: v3.6.2 was added and the previous tag Revision: v3.6.0 was removed. This reflects a newer site release and does not alter study content or user-facing information.SummaryDifference0.0%

- Check91 days agoChange DetectedThe study page now indicates recruitment is closed for participants, and several help/navigation items were added along with a revision/version note updating from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.